{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:30:20Z","timestamp":1785216620895,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.wneu.2015.07.009","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T18:03:22Z","timestamp":1436637802000},"page":"2074.e15-2074.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Primary Central Nervous System Immunomodulatory Therapy-Induced Lymphoproliferative Disorder in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature"],"prefix":"10.1016","volume":"84","author":[{"given":"Abdullah","family":"Alobaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Torlakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kongkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2015.07.009_bib1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1365-2036.2001.01023.x","article-title":"Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment","volume":"15","author":"Aithal","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.wneu.2015.07.009_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.wneu.2015.07.009_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2015.07.009_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/N82CTQ1J0XEVEFQB","article-title":"Primary central nervous system posttransplant lymphoproliferative disorders","volume":"121","author":"Castellano-Sanchez","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.wneu.2015.07.009_bib5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.24834","article-title":"Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report","volume":"116","author":"Cavaliere","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2015.07.009_bib6","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/j.1532-5415.2012.04126.x","article-title":"Primary central nervous system posttransplantation lymphoproliferative disorder in an elderly liver transplant recipient","volume":"60","author":"Dahiya","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.wneu.2015.07.009_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ajg.2012.334","article-title":"T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: results of the REFURBISH study","volume":"108","author":"Deepak","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.wneu.2015.07.009_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/acr.20016","article-title":"Genotoxicity of anti-tumor necrosis factor therapy in patients with juvenile idiopathic arthritis","volume":"62","author":"Demirkaya","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.wneu.2015.07.009_bib9","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/ajt.12211","article-title":"Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era","volume":"13","author":"Evens","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.wneu.2015.07.009_bib10","first-page":"1135","article-title":"Neurologic complications after allogeneic bone marrow transplantation","volume":"18","author":"Gallardo","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.wneu.2015.07.009_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MPG.0b013e3181e80410","article-title":"Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease","volume":"52","author":"Gidrewicz","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.wneu.2015.07.009_bib12","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/modpathol.2009.131","article-title":"Immunomodulator agent-related lymphoproliferative disorders","volume":"22","author":"Hasserjian","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.wneu.2015.07.009_bib13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/ibd.20211","article-title":"Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?","volume":"13","author":"Jones","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.wneu.2015.07.009_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/1319-2442.109563","article-title":"Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD","volume":"24","author":"Khedmat","year":"2013","journal-title":"Saudi J Kid Dis Transpl"},{"key":"10.1016\/j.wneu.2015.07.009_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.surneu.2007.04.009","article-title":"Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study","volume":"70","author":"Kim","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2015.07.009_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1227\/NEU.0b013e31828cf619","article-title":"A\u00a0case series of primary central nervous system post-transplant lymphoproliferative disorder: imaging and clinical characteristics","volume":"72","author":"Lake","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2015.07.009_bib17","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1016\/j.crohns.2012.07.025","article-title":"EBV-associated plasmablastic lymphoma in a patient with Crohn's disease after adalimumab treatment","volume":"7","author":"Liu","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.wneu.2015.07.009_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00054725-200407000-00015","article-title":"Epstein-Barr virus-associated lymphoma in Crohn's disease","volume":"10","author":"Losco","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.wneu.2015.07.009_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.wneu.2015.07.009_bib20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/acr.20228","article-title":"Anti-tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders","volume":"62","author":"Onel","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.wneu.2015.07.009_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-199501000-00016","article-title":"Central nervous system lymphomas in organ allograft recipients","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.wneu.2015.07.009_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.crohns.2011.07.002","article-title":"Plasmablastic lymphoma associated to Crohn's disease and hepatitis C virus chronic infection","volume":"5","author":"Plaza","year":"2011","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.wneu.2015.07.009_bib23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJMcpc059035","article-title":"Case records of the Massachusetts General Hospital. Case 8-2006. A 71-year-old woman with Crohn's disease and altered mental status","volume":"354","author":"Podolsky","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2015.07.009_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/jcp.2006.037556","article-title":"Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy","volume":"60","author":"Redmond","year":"2007","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.wneu.2015.07.009_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00054725-200403000-00004","article-title":"Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy","volume":"10","author":"Reijasse","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.wneu.2015.07.009_bib26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.crohns.2011.04.015","article-title":"Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy","volume":"5","author":"Rojas-Feria","year":"2011","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.wneu.2015.07.009_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archneur.1970.00480210036004","article-title":"Cerebral neoplasms associated with renal transplantation","volume":"22","author":"Schneck","year":"1970","journal-title":"Arch Neurol"},{"key":"10.1016\/j.wneu.2015.07.009_bib28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.TP.0000079253.06061.52","article-title":"Primary brain lymphomas after kidney transplantation: presentation and outcome","volume":"76","author":"Snanoudj","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.wneu.2015.07.009_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.crohns.2010.05.006","article-title":"Hepatosplenic T-cell lymphoma and inflammatory bowel disease","volume":"4","author":"Thai","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.wneu.2015.07.009_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200502000-00026","article-title":"Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease","volume":"40","author":"Thayu","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.wneu.2015.07.009_bib31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3949\/ccjm.59.5.505","article-title":"Glucocorticoids in clinical oncology","volume":"59","author":"Walsh","year":"1992","journal-title":"Cleve Clin J Med"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501500875X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501500875X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:50:21Z","timestamp":1537476621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187887501500875X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S187887501500875X"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2015.07.009","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Central Nervous System Immunomodulatory Therapy-Induced Lymphoproliferative Disorder in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2015.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}